DK671088A - THIAZOLIDINDION COMPOUNDS, THEIR USE FOR THE PREPARATION OF HYPOGLYCAEMIC AND ATHEROSCLEROSE-EFFECTIVE MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS - Google Patents

THIAZOLIDINDION COMPOUNDS, THEIR USE FOR THE PREPARATION OF HYPOGLYCAEMIC AND ATHEROSCLEROSE-EFFECTIVE MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS

Info

Publication number
DK671088A
DK671088A DK671088A DK671088A DK671088A DK 671088 A DK671088 A DK 671088A DK 671088 A DK671088 A DK 671088A DK 671088 A DK671088 A DK 671088A DK 671088 A DK671088 A DK 671088A
Authority
DK
Denmark
Prior art keywords
compounds
atherosclerose
thiazolidindion
hypoglycaemic
preparation
Prior art date
Application number
DK671088A
Other languages
Danish (da)
Other versions
DK671088D0 (en
Inventor
David Alan Clark
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK671088D0 publication Critical patent/DK671088D0/en
Publication of DK671088A publication Critical patent/DK671088A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention relates to compounds of the formula <CHEM> wherein the broken line is an optional bond, and the pharmaceutically acceptable cationic salts thereof, having utility as hypoglycemic and anti-atherosclerosis agents, and pharmaceutical compositions containing them.
DK671088A 1987-12-02 1988-12-01 THIAZOLIDINDION COMPOUNDS, THEIR USE FOR THE PREPARATION OF HYPOGLYCAEMIC AND ATHEROSCLEROSE-EFFECTIVE MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS DK671088A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/127,831 US4791125A (en) 1987-12-02 1987-12-02 Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents

Publications (2)

Publication Number Publication Date
DK671088D0 DK671088D0 (en) 1988-12-01
DK671088A true DK671088A (en) 1989-07-20

Family

ID=22432189

Family Applications (1)

Application Number Title Priority Date Filing Date
DK671088A DK671088A (en) 1987-12-02 1988-12-01 THIAZOLIDINDION COMPOUNDS, THEIR USE FOR THE PREPARATION OF HYPOGLYCAEMIC AND ATHEROSCLEROSE-EFFECTIVE MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS

Country Status (11)

Country Link
US (1) US4791125A (en)
EP (1) EP0319189B1 (en)
JP (1) JPH01186884A (en)
AT (1) ATE77087T1 (en)
DE (1) DE3871916T2 (en)
DK (1) DK671088A (en)
ES (1) ES2037243T3 (en)
FI (1) FI89356C (en)
GR (1) GR3004902T3 (en)
IE (1) IE883599L (en)
PT (1) PT89122B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968707A (en) * 1987-06-10 1990-11-06 Pfizer Inc. Oxazolidin-2-one derivatives as hypoglycemic agents
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
US5037842A (en) * 1990-06-05 1991-08-06 Pfizer Inc. Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
ATE144142T1 (en) * 1991-01-10 1996-11-15 Transcend Therapeutics Inc USE OF THIAZOLIDINE-4-CARBOXYLATE DERIVATIVES FOR THE TREATMENT OF LUNG DISEASES
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5866595A (en) * 1991-09-26 1999-02-02 The Regents Of The University Of California Calcium antagonists for treatment of vascular restenosis
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5498621A (en) * 1992-05-01 1996-03-12 Pfizer Inc. Oxazolidinedione hypoglycemic agents
US5306724A (en) * 1992-08-17 1994-04-26 Clintec Nutrition Company Method for preventing and treating atherosclerosis
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
US5641796A (en) * 1994-11-01 1997-06-24 Eli Lilly And Company Oral hypoglycemic agents
ATE353654T1 (en) 1997-06-18 2007-03-15 Smithkline Beecham Plc TREATMENT OF DIABETES WITH THIAZOLIDINDIONE AND SULPHONYLUREA
GB9715306D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
NZ511614A (en) 1998-11-12 2003-12-19 Smithkline Beecham P Modified release pharmaceutical composition containing the insulin sensitiser 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and the antidiabetic agent metaformin
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
DZ2937A1 (en) 1998-11-12 2004-03-15 Smithkline Beecham Plc New compositions of insulin sensitizers.
US6756360B1 (en) * 1998-12-24 2004-06-29 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
JP2001072592A (en) 1999-07-01 2001-03-21 Kyowa Hakko Kogyo Co Ltd Telomerase inhibitor
BR0017048A (en) * 1999-12-22 2002-11-05 Metabasis Therapeutics Inc Phosphonate bisamidate prodrugs
GB0014969D0 (en) 2000-06-19 2000-08-09 Smithkline Beecham Plc Novel method of treatment
US7563774B2 (en) 2000-06-29 2009-07-21 Metabasis Therapeutics, Inc. Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes
US6452014B1 (en) 2000-12-22 2002-09-17 Geron Corporation Telomerase inhibitors and methods of their use
US20080200453A1 (en) * 2002-07-29 2008-08-21 Cincotta Anthony H Methods of treating metabolic syndrome using dopamine receptor agonists
US9655865B2 (en) 2002-07-29 2017-05-23 Veroscience, Llc Therapeutic treatment for metabolic syndrome, type 2 diabetes, obesity, or prediabetes
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
US8268352B2 (en) * 2002-08-05 2012-09-18 Torrent Pharmaceuticals Limited Modified release composition for highly soluble drugs
US8821915B2 (en) 2002-08-09 2014-09-02 Veroscience, Llc Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
CA2577373A1 (en) * 2004-08-18 2006-03-02 Metabasis Therapeutics, Inc. Novel thiazole inhibitors of fructose 1,6-bisphosphatase
US20100035886A1 (en) 2007-06-21 2010-02-11 Veroscience, Llc Parenteral formulations of dopamine agonists
US8741918B2 (en) 2007-06-21 2014-06-03 Veroscience Llc Parenteral formulations of dopamine agonists
ES2763873T3 (en) 2007-06-21 2020-06-01 Veroscience Llc Method of treating metabolic disorders and depression with dopamine receptor agonists
US9352025B2 (en) 2009-06-05 2016-05-31 Veroscience Llc Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders
US20120094959A1 (en) 2010-10-19 2012-04-19 Bonnie Blazer-Yost Treatment of cystic diseases
US8431155B1 (en) 2012-04-30 2013-04-30 Veroscience Llc Bromocriptine formulations
WO2016071727A1 (en) 2014-11-04 2016-05-12 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the prevention and the treatment of rapidly progressive glomerulonephritis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS58118577A (en) * 1982-01-07 1983-07-14 Takeda Chem Ind Ltd Thiazolidine derivative
US4617312A (en) * 1983-01-17 1986-10-14 Pfizer Inc. Aldose reductase inhibiting 5-(2-alkoxyphenyl) thiazolidinediones
JPS6051189A (en) * 1983-08-30 1985-03-22 Sankyo Co Ltd Thiazolidine derivative and its preparation
AR240698A1 (en) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Process for the preparation of 5-(4-(2-(5-ethyl-2-pyridil)-ethoxy)benzyl)-2,4-thiazolodinedione and their salts
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
JPH1036284A (en) * 1996-07-24 1998-02-10 Sumitomo Pharmaceut Co Ltd Proteasome inhibitor

Also Published As

Publication number Publication date
FI89356C (en) 1993-09-27
DE3871916T2 (en) 1992-12-03
DK671088D0 (en) 1988-12-01
IE883599L (en) 1989-06-02
PT89122A (en) 1989-12-29
ATE77087T1 (en) 1992-06-15
EP0319189B1 (en) 1992-06-10
PT89122B (en) 1993-05-31
US4791125A (en) 1988-12-13
JPH01186884A (en) 1989-07-26
GR3004902T3 (en) 1993-04-28
FI89356B (en) 1993-06-15
EP0319189A1 (en) 1989-06-07
DE3871916D1 (en) 1992-07-16
FI885594A (en) 1989-06-03
JPH0465075B2 (en) 1992-10-16
ES2037243T3 (en) 1993-06-16
FI885594A0 (en) 1988-12-01

Similar Documents

Publication Publication Date Title
DK671088A (en) THIAZOLIDINDION COMPOUNDS, THEIR USE FOR THE PREPARATION OF HYPOGLYCAEMIC AND ATHEROSCLEROSE-EFFECTIVE MEDICINAL PRODUCTS AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
FI872864A0 (en) Process for the preparation of pharmaceutically active benzimidazole derivatives
ES8706668A1 (en) 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines.
IL74017A0 (en) N-(4-piperidinyl)bicyclic condensed 2-imidazolamine derivatives,their preparation and pharmaceutical compositions containing them
FI854227A0 (en) Process for the preparation of polypeptides useful as analgesic agent
IL85988A (en) 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them
DK317382A (en) PROCEDURE FOR THE PREPARATION OF PYRROLIDE INGREDIENTS
PT82368A (en) Substituted n-&lt;(4-piperidinyl)alkyl&gt; bicyclic condensed oxazol- and thiazolamines
KR900700458A (en) 4-amino-3-acyl quinoline derivatives and their use as inhibitors of gastric acid secretion
NZ210100A (en) 5h,11h-pyrrolo(2,1-c)(1,4)benzoxazepine derivatives and pharmaceutical compositons
DE3584608D1 (en) AMIDABKOEMMLINGE.
IL85768A (en) Benzoxazine derivatives, their preparation and pharmaceutical compositions containing them
DK364386D0 (en) 1-ALKYL-ERGOLINYL-THIOUR INGREDIENTS AND PROCEDURES FOR PREPARING THEM AND THEIR USE
ATE38029T1 (en) BENZ-TRISUBSTITUTED 2-AMINOTETRALINES.
DK0587048T3 (en) Heteroarenylpiperazines, a process for their preparation and their use as drugs
ATE51227T1 (en) CHINATE SALTS OF THE ANTI-MARARIS COMPOUND MEFLOQUINE.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment